146 related articles for article (PubMed ID: 26059602)
1. A novel anti-TNF scFv constructed with human antibody frameworks and antagonistic peptides.
Geng S; Chang H; Qin W; Lv M; Li Y; Feng J; Shen B
Immunol Res; 2015 Jul; 62(3):377-85. PubMed ID: 26059602
[TBL] [Abstract][Full Text] [Related]
2. A novel human scFv fragment against TNF-alpha from de novo design method.
Chang H; Qin W; Li Y; Zhang J; Lin Z; Lv M; Sun Y; Feng J; Shen B
Mol Immunol; 2007 Jul; 44(15):3789-96. PubMed ID: 17485112
[TBL] [Abstract][Full Text] [Related]
3. A novel domain antibody rationally designed against TNF-alpha using variable region of human heavy chain antibody as scaffolds to display antagonistic peptides.
Qin W; Feng J; Li Y; Lin Z; Shen B
Mol Immunol; 2007 Mar; 44(9):2355-61. PubMed ID: 17125837
[TBL] [Abstract][Full Text] [Related]
4. Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. A potential strategy to enhance anti-TNF therapy.
Hristodorov D; Mladenov R; Brehm H; Fischer R; Barth S; Thepen T
MAbs; 2014; 6(5):1283-9. PubMed ID: 25517313
[TBL] [Abstract][Full Text] [Related]
5. Overexpression, effective renaturation, and bioactivity of novel single-chain antibodies against TNF-alpha.
Geng S; Chang H; Qin W; Li Y; Feng J; Shen B
Prep Biochem Biotechnol; 2008; 38(1):74-86. PubMed ID: 18080912
[TBL] [Abstract][Full Text] [Related]
6. Optimization and modification of anti-rhTNF-α single chain variable fragment antibody: effective in vitro affinity maturation and functional expression of chimeric Fab.
Miao X; Li A; Chen W; Qi H; Qiu Z; Zhang Y; Zhang J; Wang M
Biomed Pharmacother; 2013 Jun; 67(5):437-44. PubMed ID: 23582792
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the novel anti-TNF-α single-chain fragment antibodies using experimental and computational approaches.
Pourtaghi-Anvarian S; Mohammadi S; Hamzeh-Mivehroud M; Alizadeh AA; Dastmalchi S
Prep Biochem Biotechnol; 2019; 49(1):38-47. PubMed ID: 30735094
[TBL] [Abstract][Full Text] [Related]
8. Targeting TNF-alpha with a tetravalent mini-antibody TNF-TeAb.
Liu M; Wang X; Yin C; Zhang Z; Lin Q; Zhen Y; Huang H
Biochem J; 2007 Sep; 406(2):237-46. PubMed ID: 17472572
[TBL] [Abstract][Full Text] [Related]
9. Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.
Lehmann A; Wixted JH; Shapovalov MV; Roder H; Dunbrack RL; Robinson MK
MAbs; 2015; 7(6):1058-71. PubMed ID: 26337947
[TBL] [Abstract][Full Text] [Related]
10. Downstream characterization of anti-TNF-α single chain variable fragment antibodies.
Abdolalizadeh J; Nouri M; Zolbanin JM; Baradaran B; Barzegari A; Omidi Y
Hum Antibodies; 2012; 21(1-2):41-8. PubMed ID: 22885959
[TBL] [Abstract][Full Text] [Related]
11. Designing a new bispecific tandem single-chain variable fragment antibody against tumor necrosis factor-α and interleukin-23 using in silico studies for the treatment of rheumatoid arthritis.
Barkhordari A; Mahnam K; Mirmohammad-Sadeghi H
J Mol Model; 2020 Aug; 26(9):225. PubMed ID: 32778954
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel anti-human TNF-alpha murine monoclonal antibody with high binding affinity and neutralizing activity.
Song MY; Park SK; Kim CS; Yoo TH; Kim B; Kim MS; Kim YS; Kwag WJ; Lee BK; Baek K
Exp Mol Med; 2008 Feb; 40(1):35-42. PubMed ID: 18305396
[TBL] [Abstract][Full Text] [Related]
13. A single-chain TNF receptor antagonist is an effective inhibitor of TNF mediated cytotoxicity.
Moosmayer D; Dübel S; Brocks B; Watzka H; Hampp C; Scheurich P; Little M; Pfizenmaier K
Ther Immunol; 1995 Feb; 2(1):31-40. PubMed ID: 7553069
[TBL] [Abstract][Full Text] [Related]
14. Expression of a Tagless Single-Chain Variable Fragment (scFv) of Anti-TNF-α by a Salt Inducible System and its Purification and Characterization.
Sain A; Sen P; Venkataraman K; Vijayalakshmi MA
Protein Pept Lett; 2021; 28(11):1272-1280. PubMed ID: 34551688
[TBL] [Abstract][Full Text] [Related]
15. [Autoimmune aspects of treatment with TNF-alpha inhibitors].
Kolarz B; Targońska-Stepniak B; Darmochwał-Kolarz D; Majdan M
Postepy Hig Med Dosw (Online); 2007 Aug; 61():478-84. PubMed ID: 17786135
[TBL] [Abstract][Full Text] [Related]
16. Cloning, expression, purification and characterization of a single chain variable fragment specific to tumor necrosis factor alpha in Escherichia coli.
Sushma K; Vijayalakshmi MA; Krishnan V; Satheeshkumar PK
J Biotechnol; 2011 Dec; 156(4):238-44. PubMed ID: 21763363
[TBL] [Abstract][Full Text] [Related]
17. De novo design TNF-alpha antagonistic peptide based on the complex structure of TNF-alpha with its neutralizing monoclonal antibody Z12.
Qin W; Feng J; Li Y; Lin Z; Shen B
J Biotechnol; 2006 Aug; 125(1):57-63. PubMed ID: 16522339
[TBL] [Abstract][Full Text] [Related]
18. Humanization of an agonistic anti-death receptor 4 single chain variable fragment antibody and avidity-mediated enhancement of its cell death-inducing activity.
Lee SH; Park DW; Sung ES; Park HR; Kim JK; Kim YS
Mol Immunol; 2010 Jan; 47(4):816-24. PubMed ID: 19864027
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological efficacy of anti-IL-1β scFv, Fab and full-length antibodies in treatment of rheumatoid arthritis.
Qi J; Ye X; Ren G; Kan F; Zhang Y; Guo M; Zhang Z; Li D
Mol Immunol; 2014 Feb; 57(2):59-65. PubMed ID: 24091292
[TBL] [Abstract][Full Text] [Related]
20. [Construction and application of a lentiviral vector of single-chain variable fragment antibody against human hepatocyte growth factor receptor].
Chen Y; Guo J; Yin Y; Jiang M; Zhu H; Zhang G; Li B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Sep; 30(9):960-3. PubMed ID: 25200159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
